Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Headache Week 2026: March 15-21.

The journal of headache and pain·2026
Same author

WHO's Global status report on neurology: mixed messages for people with headache disorders.

The journal of headache and pain·2026
Same author

Venous manometry triage in refractory idiopathic intracranial hypertension: imaging and criteria validity.

Journal of neurointerventional surgery·2025
Same author

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study.

Headache·2025
Same author

Correction: The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical federation.

The journal of headache and pain·2025
Same author

The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical Federation.

The journal of headache and pain·2025
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.9K

Noninvasive neuromodulation in cluster headache.

Miguel J A Láinez1, Rigmor Jensen

  • 1aDepartment of Neurology, Clinic University Hospital, Catholic University of Valencia, Valencia, Spain bDepartment of Neurology, Danish Headache Center, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark.

Current Opinion in Neurology
|April 19, 2015
PubMed
Summary
This summary is machine-generated.

Noninvasive vagal nerve stimulation offers a promising, less invasive alternative for managing intractable cluster headaches. This approach has shown effectiveness in reducing weekly attacks with a low rate of mild adverse events.

More Related Videos

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

10.3K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.9K

Related Experiment Videos

Last Updated: Apr 14, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.9K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

10.3K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.9K

Area of Science:

  • Neurology
  • Neurosurgery

Background:

  • Cluster headache is a debilitating neurological condition.
  • Medically intractable cases often require neuromodulation for management.
  • Invasive neuromodulation techniques carry risks and complications.

Purpose of the Study:

  • To review current data on noninvasive neuromodulation for cluster headache.
  • To evaluate the efficacy and safety of noninvasive devices.

Main Methods:

  • Review of studies utilizing noninvasive neuromodulation devices.
  • Analysis of clinical practice data and randomized trials.

Main Results:

  • Noninvasive vagal nerve stimulation demonstrated a reduction in cluster attack frequency.
  • The treatment was associated with a low incidence of mild adverse events.
  • Results stem from clinical practice and one randomized clinical trial.

Conclusions:

  • Noninvasive neuromodulation, specifically vagal nerve stimulation, presents a potentially easier alternative for intractable cluster headache.
  • Further controlled studies are needed to confirm efficacy and explore mechanisms of action.